IP Verse

Combination Therapy Using Inhibitors Of Human Growth And Differentiation Factor 15 (Gdf-15) And Immune Checkpoint Blockers

Patent No. EP3355919 (titled "Combination Therapy Using Inhibitors Of Human Growth And Differentiation Factor 15 (Gdf-15) And Immune Checkpoint Blockers") was filed by Julius Maximilians Universitt Wrzburg on Sep 30, 2016. The application was issued on Dec 7, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERSep 6, 2023PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3355919

JULIUS MAXIMILIANS UNIVERSITT WRZBURG
Application Number
EP16778750A
Filing Date
Sep 30, 2016
Status
Granted And Under Opposition
Nov 4, 2022
Publication Date
Dec 7, 2022
External Links
Slate, Register , Google Patents